Identification of diagnostic candidate genes in COVID-19 patients with sepsis

Jiuang Li1, Shiqian Pu1, Lei Shu1

  • 1Department of Critical Care Medicine, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.

PubMed

Insights

This study identified five key genes (CD3D, IL2RB, KLRC, CD5, and HLA-DQA1) as potential diagnostic markers for Coronavirus Disease 2019 (COVID-19) patients experiencing sepsis. These findings aid in developing new diagnostic tools for this critical condition.

Area of Science:

  • Genomics
  • Immunology
  • Bioinformatics

Background:

  • Coronavirus Disease 2019 (COVID-19) and sepsis share complex pathophysiological links.
  • Accurate and early diagnosis is crucial for managing COVID-19 patients with sepsis.

Purpose of the Study:

  • To identify pivotal diagnostic candidate genes for COVID-19 patients with sepsis.
  • To evaluate the diagnostic utility of identified genes using machine learning and immune infiltration analysis.

Main Methods:

  • Utilized Gene Expression Omnibus (GEO) datasets for COVID-19 and sepsis.
  • Applied Linear Models for Microarray Data (LIMMA), weighted gene co-expression network analysis (WGCNA), and protein-protein interaction (PPI) networks.
  • Employed machine learning algorithms (LASSO, Random Forest) and Receiver Operating Characteristic (ROC) curves for gene selection and diagnostic value assessment.

Main Results:

  • Identified 3,438 differentially expressed genes (DEGs) in COVID-19 and 595 common genes in sepsis.
  • 329 common DEGs between COVID-19 and sepsis were enriched in immune system pathways.
  • Selected 8 diagnostic genes with Area Under the Curve (AUC) > 0.9, including five core genes (CD3D, IL2RB, KLRC, CD5, HLA-DQA1) associated with immune infiltration.

Conclusions:

  • Five core genes (CD3D, IL2RB, KLRC, CD5, HLA-DQA1) show diagnostic utility in COVID-19 patients with sepsis.
  • These genes are potential peripheral blood diagnostic markers.
  • Findings support the development of novel diagnostic strategies for sepsis in COVID-19.
Abstract